Cargando…
Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
PURPOSE: To inform development of procedures for using tumor-treating field arrays (TTFields) during glioblastoma radiation therapy by determining whether the placement and repositioning of arrays affects target volume coverage and cranial skin dose. METHODS AND MATERIALS: Radiation plans from 10 co...
Autores principales: | Stachelek, Gregory C., Grimm, Jimm, Moore, Joseph, Huang, Ellen, Spoleti, Nicholas, Redmond, Kristin J., Lim, Michael, Bettegowda, Chetan, Kleinberg, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004938/ https://www.ncbi.nlm.nih.gov/pubmed/32051891 http://dx.doi.org/10.1016/j.adro.2019.08.005 |
Ejemplares similares
-
Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone
por: Miller, Sean, et al.
Publicado: (2019) -
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage
por: Shen, Colette J., et al.
Publicado: (2018) -
Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas
por: Nesseler, Jean Philippe, et al.
Publicado: (2018) -
Intensity Modulated Radiation Therapy Versus Volumetric Arc Radiation Therapy in the Treatment of Glioblastoma—Does Clinical Benefit Follow Dosimetric Advantage?
por: Sheu, Tommy, et al.
Publicado: (2018) -
Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
por: Bovi, Joseph A., et al.
Publicado: (2019)